| Date Filed | Type | Description |
| 06/16/2023 |
4
| Paya Carlos V (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/15/2023 |
4
| Paya Carlos V (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2021 |
4
| Paya Carlos V (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 30,000 options to buy
@ $22.02, valued at
$660.6k
|
|
| 10/29/2021 |
3
| Paya Carlos V (Director) has filed a Form 3 on Vaxcyte, Inc. |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Granted 13,369 shares
@ $0
Granted 20,993 options to buy
@ $3.74, valued at
$78.5k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2020 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Exercised 2,500 restricted stock units
@ $0 |
|
| 06/05/2019 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Granted 3,987 shares
@ $0
Granted 6,796 options to buy
@ $13.41, valued at
$91.1k
|
|
| 05/24/2019 |
4
| Paya Carlos V (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 31,349 shares
@ $0 |
|
| 05/24/2019 |
3
| Paya Carlos V (Director) has filed a Form 3 on Mallinckrodt plc |
| 04/04/2019 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 35,576 shares
@ $5.85, valued at
$208.1k
Disposed/sold 121,000 restricted stock units
@ $0
Disposed/sold 195,289 options to buy
@ $1.31, valued at
$255.8k
Disposed/sold 67,277 options to buy
@ $1.31, valued at
$88.1k
Disposed/sold 61,161 options to buy
@ $1.48, valued at
$90.5k
Disposed/sold 244,648 options to buy
@ $1.23, valued at
$300.9k
Disposed/sold 175,000 options to buy
@ $5.6, valued at
$980k
Disposed/sold 216,500 options to buy
@ $4.05, valued at
$876.8k
Disposed/sold 263,009 options to buy
@ $4.4, valued at
$1.2M
Disposed/sold 293,000 options to buy
@ $1.31, valued at
$383.8k
|
|
| 03/26/2019 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Exercised 2,500 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2019 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 63,000 shares
@ $0
Sold 13,014 shares
@ $1.5822, valued at
$20.6k
Granted 293,000 options to buy
@ $1.31, valued at
$383.8k
|
|
| 07/19/2018 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 12,743 options to buy
@ $8.92, valued at
$113.7k
Granted 8,496 options to buy
@ $4.4, valued at
$37.4k
Disposed/sold 66,767 options to buy
@ $8.92, valued at
$595.6k
Granted 44,512 options to buy
@ $4.4, valued at
$195.9k
Disposed/sold 2,450 options to buy
@ $31, valued at
$76k
Granted 1,225 options to buy
@ $4.4, valued at
$5.4k
Disposed/sold 97,550 options to buy
@ $31, valued at
$3M
Granted 48,775 options to buy
@ $4.4, valued at
$214.6k
Disposed/sold 90,000 options to buy
@ $13, valued at
$1.2M
Granted 60,000 options to buy
@ $4.4, valued at
$264k
Disposed/sold 5,471 options to buy
@ $19.39, valued at
$106.1k
|
|
| 06/01/2018 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Granted 6,100 shares
@ $0
Exercised 5,000 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0
Granted 10,600 options to buy
@ $5.57, valued at
$59k
|
|
| 03/26/2018 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Exercised 2,500 restricted stock units
@ $0 |
|
| 02/15/2018 |
4
| Paya Carlos V (Director) has filed a Form 4 on FLUIDIGM CORP|
Txns:
| Granted 5,952 shares
@ $0 |
|
| 01/08/2018 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 46,500 shares
@ $0
Sold 7,970 shares
@ $4.1715, valued at
$33.2k
Granted 216,500 options to buy
@ $4.05, valued at
$876.8k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |